SCHEMBL6545035

SCHEMBL6545035

COc1ccc(C[C@H]2C3=C(CCCC3)CCN2C(C)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
MTNR1B P49286 4/20 0.43
MTNR1A P48039 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
DPP4 P27487 1/20 0.39
FAP Q12884 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9151971 0.89 CYP2D6 (0.61) CYP3A4CYP2D6CYP2C19SMN1; SMN2BCHE
SCHEMBL11757293 0.89 CYP2D6 (0.61) CYP3A4CYP2D6CYP2C19SMN1; SMN2BCHE
SCHEMBL11447599 0.87 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C19MTNR1BSMN1; SMN2
SCHEMBL11465395 0.86 CYP3A4 (0.45) CYP3A4CYP2D6CYP2C19MTNR1BSMN1; SMN2
SCHEMBL11755929 0.86 HSD11B1 (0.46) CYP3A4CYP2D6CYP2C19MTNR1BSMN1; SMN2
SCHEMBL27825960 0.86 ABCB1 (0.44) MTNR1BMTNR1AMEN1KMT2A
SCHEMBL19427415 0.85 CYP3A4 (0.49) CYP3A4CYP2D6CYP2C19SMN1; SMN2BCHE
SCHEMBL10568585 0.81 TSHR (0.42) SMN1; SMN2MEN1KMT2AGAA
SCHEMBL16596978 0.81 BCHE (0.53) CYP2D6BCHEACHEMAPK1
SCHEMBL2067120 0.81 BCHE (0.53) CYP2D6BCHEACHEMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0834506-B1 Process for the preparation of (9alpha, 13alpha, 14alpha)-1-(3-Methoxymorphinan-17-yl)alkanones HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
EP-0583433-B1 DIPHOSPHINE LIGANDS HOFFMANN LA ROCHE (CH) 1999-05-12 EP disclosed
EP-0579797-B1 DIPHOSPHINE LIGANDS HOFFMANN LA ROCHE (CH) 1999-04-21 EP disclosed
EP-0647648-B1 Optically active phosphorus compounds HOFFMANN LA ROCHE (CH) 1999-03-10 EP disclosed
EP-0834506-A1 Process for the preparation of (9alpha, 13alpha, 14alpha)-1-(3-Methoxymorphinan-17-yl)alkanones F. HOFFMANN-LA ROCHE AG (CH) 1998-04-08 EP disclosed
US-5516944-A ENANTIOMORPHS WITH PHOSPHINE GROUPS FOR FORMING METAL COMPLEXES HOFFMANN-LA ROCHE INC. (US) 1996-05-14 US disclosed
US-5457219-A Used in making hydrogenation catalysts and isomerization catalysts HOFFMANN-LA ROCHE INC. (US) 1995-10-10 US disclosed
EP-0397042-B1 Process for the preparation of isoquinoline derivatives HOFFMANN LA ROCHE (CH) 1995-08-16 EP disclosed
US-5430191-A Assymetric hydrogenation catalysts, enantioselective hydrogen displacement HOFFMANN-LA ROCHE INC. (US) 1995-07-04 US disclosed
EP-0647648-A1 Optically active phosphorus compounds F. HOFFMANN-LA ROCHE AG (CH) 1995-04-12 EP disclosed
EP-0315886-B1 Isoquinoline derivatives, their manufacture and use HOFFMANN LA ROCHE (CH) 1995-02-15 EP disclosed
US-5360908-A Isomeriation, assymetric hydrogenation HOFFMAN-LAROCHE INC. (US) 1994-11-01 US disclosed
EP-0583433-A1 DIPHOSPHINE LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 1994-02-23 EP disclosed
WO-1993015090-A1 DIPHOSPHINE LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 1993-08-05 WO disclosed
EP-0397042-A2 Process for the preparation of isoquinoline derivatives F. HOFFMANN-LA ROCHE AG (CH) 1990-11-14 EP disclosed
US-4857648-A Isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 1989-08-15 US disclosed
EP-0315886-A2 Isoquinoline derivatives, their manufacture and use F. HOFFMANN-LA ROCHE AG (CH) 1989-05-17 EP disclosed